Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing
Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection
Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University